Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Anecortave acetate shows efficacy in maintaining visual acuity of patients with wet AMD

Nov. 10, 2004

Long-term benefits of ranibizumab in neovascular AMD patients

Nov. 9, 2004

Inspire licenses novel glaucoma technology

Nov. 9, 2004

Serotonin receptor agonists for treatment of ocular hypertension and glaucoma

Nov. 4, 2004

Series B financing at Othera to accelerate pipeline development

Oct. 27, 2004

Treatment under way in TheraSight trial

Oct. 25, 2004

Visudyne VIO study recommended to continue

Oct. 18, 2004

Anecortave acetate study results

Oct. 18, 2004

Cand5 enters phase I study for AMD

Oct. 14, 2004

Photrex chosen as new brand name for SnET2

Oct. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...